Steves Distributing, LLC
Agreed to an FTC consent order over allegedly unsupported claims that CBD products treat cancer and diabetes
This entry is about the United States — not the country you picked in the header.
According to Federal Trade Commission, Dec 17, 2020 · Read the source · +1 more
Resolved or closed
The source lists this matter as resolved or closed. The entry stays public so the record remains available.
Summary
Steves Distributing, LLC, which sold products as Steve's Goods, was among the six companies in the FTC's December 2020 enforcement sweep against deceptive CBD marketing, Operation CBDeceit. The FTC said the company had sold CBD and CBG tinctures, gummies, capsules, balms, suppositories, bath products and coffee through its website and social media since 2018. The agency alleged that the marketing presented the products as effective alternatives to prescription drugs and as treatments for conditions including Alzheimer's disease, cancer and diabetes, and made other health claims it considered unsupported, such as preventing heart attacks. The company and its principals agreed to an administrative consent order, finalized on March 5, 2021, that bars disease-treatment claims without human clinical testing, requires competent scientific evidence for other health claims, and required a $75,000 payment to the FTC and notice to consumers. The FTC lists the matter as closed.
What the source found
- The FTC alleged claims that the products were effective alternatives to prescription medications.
- The FTC cited claims about treating Alzheimer's disease, cancer and diabetes and preventing heart attacks.
- The consent order bars such claims without human clinical testing.
- The respondents were required to pay $75,000 to the FTC and notify consumers.
Products named
- CBD and CBG tinctures
- CBD gummies and capsules
- CBD topicals
- CBD coffee
Timeline
FTC announces administrative complaint and proposed consent order
FTC approves final decision and order; case closed
Sources
- Regulator
Federal Trade Commission · Dec 17, 2020
FTC Announces Crackdown on Deceptively Marketed CBD Products - Regulator
Federal Trade Commission · Mar 5, 2021
Steves Distributing, LLC, In the Matter of
Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.
Status notes
Settled through an administrative consent order in 2021; the FTC lists the case as closed. The order's restrictions on health claims remain in force. Current trading status of the business was not verified.
Comments
No comments yet.
Related entries
The full Red ListTell us what happened
Every report is read by a person. You don’t need to prove anything, and we never publish your name.
- A moderator reads your report and checks the link against the Red List and our seller records.
- We look for an authoritative source — a regulator, court, police or consumer-protection finding.
- When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.